Cytek Biosciences.
biotechnology company and producer of scientific instruments
- Reports this week
- 0
- Active events
- 2
- Connections
- 25
What's happening
Active this week
Earlier this month
One to three months ago
-
Cytek Biosciences reported revenue of $48.1 million, noting growth driven by U.S. and China performance, but also citing geopolitical headwinds.Some support1 report
-
Boston Partners bought a new position in shares of Cytek Biosciences.Some support1 report
-
Wenbin Jiang was appointed CEO of Cytek Biosciences.Some support1 report
Gone quiet
No new reports in 90+ days-
Cytek Biosciences, headquartered in Fremont, filed with the SEC and announced its Northern Lights system is available for clinical use in China.Some support2 reports
-
The market was rising on July 1, 2025, supporting the relevance of penny stocks for Cytek Biosciences.Speculative1 report
-
Cytek Biosciences, headquartered in Fremont, participated in a UBS Precision Medicine Summit and a Morgan Stanley conference in August 2025.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around Cytek Biosciences this week
News at the entities that move Cytek Biosciences most-
Europe OperationalThe European Central Bank is forced to raise interest rates due to energy price shocks from the Iran war and an influx of Chinese exports.Moves Cytek Biosciences
-
Securities and Exchange Commission StructuralBlackRock, the manager of the iShares Core MSCI EAFE ETF, has made required filings with the Securities and Exchange Commission regarding institutional holdings.Moves Cytek Biosciences
-
China StructuralBasra hosts the Grand Faw Port project, serving as a key transit hub for trade routes connecting China and Europe.Moves Cytek Biosciences
-
Fremont Shared contextAehr Test Systems is holding an investor summit in San Francisco.Moves Cytek Biosciences
-
Boston Partners TransactionalOn June 26, 2026, multiple financial firms made investment moves in Wells Fargo, alongside the successful completion of the company's 2026 Fed stress test.Moves Cytek Biosciences
Connections
The 11 strongest of 25, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FSP Structural
Cytek Biosciences utilizes patented technology provided by FSP for its operational instruments and services.
-
Northern Lights Structural
Northern Lights functions as a core platform system utilized by Cytek Biosciences.
-
Guava Structural
Guava is identified as one of Cytek Biosciences' product brands.
-
Wenbin Jiang Structural
Wenbin Jiang serves as the Chief Executive Officer of Cytek Biosciences.
-
China Structural
Cytek Biosciences has established manufacturing facilities and clinical use presence within China.
-
Europe Operational
Cytek Biosciences' performance is directly influenced by the macroeconomic weakness and geopolitical dynamics of Europe.
-
Borealis Operational
Cytek Biosciences launched a flow cytometer product named Borealis.
-
Securities and Exchange Commission Structural
Cytek Biosciences is subject to formal regulatory oversight and filing requirements by the Securities and Exchange Commission.
Show all 11 connections
-
Boston Partners Transactional
The relationship is defined by a single investment event where Boston Partners acquired a new position in the shares of the other company.
-
Mac Operational
A company's cloud platform is available on Mac or PC devices, linking its operations to the ecosystem associated with the individual B.
-
Fremont Shared context
Cytek Biosciences is located and headquartered in Fremont, California.
History
Events by the month they beganSeptember 2026
1 eventAugust 2026
3 eventsJune 2026
5 events- The Aurora platform successfully enabled marker analysis per sample, leading to Cytek Biosciences gaining market share due to its usability and pricing.
- Cytek Biosciences operates within the Life Sciences industry.
- Cytek Biosciences, headquartered in Fremont, filed with the SEC and announced its Northern Lights system is available for clinical use in China.
- The market was rising on July 1, 2025, supporting the relevance of penny stocks for Cytek Biosciences.
- Cytek Biosciences, headquartered in Fremont, participated in a UBS Precision Medicine Summit and a Morgan Stanley conference in August 2025.